Nalaganje...
Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence
With the lack of effective therapy, chemoprevention and vaccination, focusing on the immediate repurposing of existing drugs gives hope of curbing the pandemic. Interestingly, montelukast, a drug usually used in asthma, may be proposed as a potential adjuvant therapy in COVID-19. The aim of the pres...
Shranjeno v:
| izdano v: | Front Pharmacol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7500361/ https://ncbi.nlm.nih.gov/pubmed/33013375 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01344 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|